Drug archive
Rosiglitazone and Metformin (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antidiabetic agent
Description
Rosiglitazone and metformin (ROS-e-glit-a-zone and met-FOR-min) combination is used to treat high blood sugar levels that are caused by a type of diabetes mellitus or sugar diabetes called type 2 diabetes. Normally, after you eat, your pancreas releases insulin to help your body store excess sugar for later use. This process occurs during normal digestion of food. In type 2 diabetes, your body does not work properly to store the excess sugar and the sugar remains in your bloodstream. Chronic high blood sugar can lead to serious health problems in the future. Proper diet is the first step in managing type 2 diabetes but often medicines are needed to help your body. Rosiglitazone helps your body use the insulin better and it reduces the amount of insulin in your body. Metformin has reduces the absorption of sugar, reduces the release of stored sugar from the liver, and helps your body's cells use sugar better.
This medicine is available only with your doctor's prescription, in the following dosage forms:
- Tablets (U.S.)
- Tablets (Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Avandamet
In Canada -
- Avandamet